Staging by Lymph Node Categories Shown to Better Predict Survival in Patients With Oropharyngeal CancerMarch 15, 2016
The current staging system for oropharyngeal cancer does not adequately differentiate HPV-positive from HPV-negative OPC. These researchers suggest regional OPC lymph node (N) categories and nasopharyngeal N categories might be more useful in staging HPV-positive OPC.
No evidence that interferon is necessary or helpful in cases of melanoma with minimal metastasis to the lymph nodes, according to the final results of the Sunbelt Melanoma Trial.
Recent trial data indicate that axillary lymph node dissection (ALND) can be safely omitted in select patients, according to a research presented at the 2015 San Antonio Breast Cancer Symposium.
Internal mammary lymph nodes (IMLNs) identified at implant-protocol breast magnetic resonance imaging (MRI) are more likely to be benign than malignant.
Radiation to the lymph nodes as well as the standard treatment of whole-breast irradiation after breast-conserving surgery does not confer an overall survival benefit.
The effect of irradiation of regional nodes in patients with stage I, II, or III breast cancer on overall survival is very limited, according to a study.
Women with cervical or endometrial cancer can safely receive extended-field intensity modulated radiation therapy (EF-IMRT) without increased risk of duodenal toxicity.
The growth of metastases in lymph nodes does not require new blood vessels, but rather utilizes existing blood vessels.
Although not usually recommended for women with localized cancer undergoing breast-conserving surgery, axillary lymph node evaluation is performed frequently in women with ductal carcinoma in situ (DCIS) breast cancer.
Not all women with lymph node-positive breast cancer treated with chemotherapy before surgery need to have all underarm nodes removed, new research indicates.
A risk stratification model, based on lymph node characteristics, can confirm a negative classification of lung cancer with a high level of confidence.
A study from the University of Texas MD Anderson Cancer Center reveals a disparity in use of sentinel lymph node biopsy between black and white women.
Although sentinel lymph node biopsy (SLNB) use has increased in all patients with breast cancer, black women are consistently less likely than white women to have SLNB, according to a study.
For patients with breast cancer with a positive sentinel node treatment with axillary lymph node dissection is associated with more morbidity than axillary radiotherapy, according to a study.
For the first time, researchers have shown the predictive power of a group of overlooked lymph nodes that could serve as a better tool to stage and ultimately treat patients with malignant pleural mesothelioma.
Giving radiation therapy to the lymph nodes located behind the breast bone and above the collar bone to patients with early breast cancer improves overall survival without increasing side effects.
Measuring levels of the molecule microRNA-31 might accurately determine if a patient's lung cancer has spread to nearby lymph nodes.
Breast tumors that carry breast cancer stem and progenitor cells with mutations in specific oncogenes are significantly more likely than other breast cancers to metastasize to the lymph nodes, researchers reported.
After a breast cancer operation, the removed tumor is always examined, as its subtype can provide an indication of how aggressive the disease is.
Subclassification of melanoma by NSLN tumor status suggested that positivity is a significant prognostic factor in patients with advanced melanoma.
SPECT/CT-aided sentinel lymph node excision improves detection of metastases, outcome.
Sentinel lymph node biopsy may be used in place of inguinal femoral lymphadenectomy.
TIL is an independent predictor of sentinel lymph node status and survival in cutaneous melanoma.
After lymph node removal, painful swelling may result. This fact sheet educates patients about how to manage symptoms.
Despite having been treated with negative-node protocols, no adverse effect in early-stage disease
Node size, volume, and number affected in patients with a history of invasive cutaneous melanoma
A collection of recent articles from the medical literature discuss surgically removing and evaluating an increasing number of lymph nodes in patients with colorectal cancer; Black women with breast cancer have a greater chance of dying from the disease than white women; chemotherapy plus radiotherapy with or without resection (preferably lobectomy) are options for patients with stage IIIA (N2) non-small cell lung cancer; respecting the patient's preferences for treatment is a key component of high quality end of life care; and frankincense oil could prove a useful gift in the treatment of bladder cancer
- Ruxolitinib May Improve Symptom Control in Patients With CLL
- 3-drug Regimen With Ricolinostat Active, Safe in Multiple Myeloma
- Lung Cancer Navigator App Aims to Help Patients Understand Disease
- Adding Bortezomib to Rd Improves PFS, OS in Newly Diagnosed Myeloma
- Racial Disparities Persist in Myeloma Treatment Use
- Optimal Timing of Influenza Vaccination in Patients Receiving Chemotherapy
- Racial Disparities Persist in Myeloma Treatment Use
- Hypnosis and Its Use in Cancer Treatment
- Longer Dosing Interval of Zoledronic Acid May Be Acceptable for Bone Metastases
- Melanoma Incidence Still on the Rise in Parts of the United States
- Comprehensive Report Looks at Benefits and Harms of Medical Cannabis
- ASCO: Moderate Activity Linked to Longer Survival in Advanced CRC
- MABp1 Improves Symptoms vs Placebo in Colorectal Cancer
- Obesity Increases Risk for Transformation of MGUS to Multiple Myeloma
- Excessive FDA Regulation Driving High Drug Prices
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|